Tag: revascularisation

Female sex “should be considered an independent risk factor” for new...

A preliminary report lends evidence to support female sex being considered as an independent risk factor for new stroke occurrence after carotid revascularisation in...
carotid stenosis women

Carotid stenosis in women: Should the approach differ?

The existing evidence on whether women with carotid stenosis experience inferior treatment outcomes compared to men is mixed—and this uncertainty is reflected in the...

Study highlights need to extend scope of cerebrovascular health disparities research

A new research letter in Stroke outlines use of the novel National Institutes of Health (NIH) ‘All of Us’ research programme dataset of diverse...
sensome clot out

Sensome begins first-in-human trial of AI-powered stroke guidewire

Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...
carotid disease stenting

Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...

Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients. Best...
rapid medical TIGERTRIEVER

First US ischaemic stroke patients treated with Rapid Medical’s novel clot...

The first US patients have been treated with the FDA-cleared TIGERTRIEVER revascularisation device (Rapid Medical). TIGERTRIEVER is the first physician-adjustable stent retriever, according to...

Medtronic gets US FDA clearance for Riptide aspiration system

The Riptide aspiration system is intended for use in the revascularisation of patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease...

Neuravi announces European launch of EmboTrap II stent retriever for treatment...

Neuravi has received CE mark approval for newly available enhancements to its EmboTrap stent retriever platform, the EmboTrap II revascularisation device. The company will...

Randomised trial of Penumbra 3D revascularisation device meets primary endpoints

The Penumbra 3D trial of the company’s 3D revascularisation device has successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy...